AzTrials
AzTrials

Amputation, TraumaticNCT02956603

Studying Electromyographic Activity in Patients With Upper Limb Amputations

A study testing Fine wire EMG electrodes in people with Amputation, Traumatic, run by University of Michigan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary purpose of this study is to determine the extent to which the Regenerative Peripheral Nerve Interface ( i.e. reinnervation of partial muscle grafts by residual peripheral nerves) enables both the generation of high-performance motor control signals for prosthetic limbs, and the input of sensory percepts by… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Amputation, Traumatic
What is being tested?
Fine wire EMG electrodes
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
No sites listed yet
Study dates
6 Sep 2015to 12 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For the prosthetic control graft arm:
  • Must have previously undergone upper limb amputation
  • Must be otherwise healthy (e.g. no severe pain syndromes or untreated mental health disorders)
  • Must be American Society of Anesthesiologists (ASA) Class I (low surgical risk)
  • Must have sufficient soft tissue quality to support performance of the operative procedures
  • Must have NOT previously received the partial muscle graft surgery
Show all 13Show fewer
  • For the neuroma graft arm:
  • Must have previously undergone upper limb amputation
  • Must be otherwise healthy (e.g. no severe pain syndromes or untreated mental health disorders)
  • Must have previously received the partial muscle graft surgery
  • For the able-bodied arm:
  • Must have NOT undergone upper limb amputation
  • Must be in good health

Who cannot join

  • For the prosthetic control graft arm:
  • Participants sustaining severe crushing or avulsion injuries with substantial superficial and deep scarring, may not be appropriate candidates for inclusion in the study
  • For the able-bodied arm:
  • Participants with a history of nerve pain may not be appropriate candidates for inclusion in the study

About this study

The primary purpose of this study is to determine the extent to which the Regenerative Peripheral Nerve Interface ( i.e. reinnervation of partial muscle grafts by residual peripheral nerves) enables both the generation of high-performance motor control signals for prosthetic limbs, and the input of sensory percepts by electrical stimulation.

Being tested
Fine wire EMG electrodes
Medical subject headings
Amputation, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fine wire EMG electrodesOther

    Electrodes placed either in partial muscle grafts or in intact muscle to record and stimulate

Study groups in NCT02956603
Study groupRoleWhat they receive
Neuroma GraftExperimentalIn this arm, participants have already had partial muscle grafts placed on the amputated nerves to control neuroma growth. The investigators will place small electrodes percutaneously into the muscle grafts to record EMG signals and electrically stimulate the implanted nerves.
Receives: Other: Fine wire EMG electrodes
Prosthetic Control GraftExperimentalIn this arm, participants will have an initial surgery to place partial muscle grafts on the amputated nerves. After a healing period, the investigators will place small electrodes percutaneously into the muscle grafts to record EMG signals and electrically stimulate the implanted nerves.
Receives: Other: Fine wire EMG electrodes
Able BodiedExperimentalThe investigators will place small electrodes percutaneously into intact muscles in the arm to record EMG signals and electrically stimulate the intact nerves nearby.
Receives: Other: Fine wire EMG electrodes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amplitude of EMG signal

    Measured: <4 hours

  2. Number of separate sensory percepts evoked

    Measured: <4 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2016 (estimated)
  2. Study start6 Sep 2015
  3. Primary completion12 Nov 2020
  4. Study completion12 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02956603
Sponsor's protocol ID
HUM00088547
Other IDs
N66001-16-1-4006
Status last verified
Jul 2024
First submitted
2 Nov 2016
Last updated
23 Jul 2024
Results posted
No
Data monitoring committee
No
Individual data sharing
No: Individual participant data will not be shared

Questions about this trial

What is this clinical trial studying?

A study testing Fine wire EMG electrodes in people with Amputation, Traumatic, run by University of Michigan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amplitude of EMG signal (time frame: <4 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in